Whalerock Point Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Whalerock Point Partners's XBI Position: Q3 2025 in Review
Whalerock Point Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 3,295 shares — an estimated $273K sold.
Whalerock Point Partners first reported a position in XBI in Q3 2019 and held it in 24 quarters. The position peaked at $605K in Q4 2020. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Whalerock Point Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
- Whalerock Point Partners sold 3,295 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $273K.
- Whalerock Point Partners first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 24 quarters.
- Whalerock Point Partners's State Street SPDR S&P Biotech ETF position peaked at $605K in Q4 2020.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Whalerock Point Partners's 13F filing for Q3 2025, filed 12 Nov 2025.